Allocation of resources and psychosis

References

• Carr V J, Neil A L, Halpin S A, Holmes S, Lewin T J. Costs of schizophrenia and other psychoses in urban Australia: findings from the Low Prevalence (Psychotic) Disorders Study. Australian and New Zealand Journal of Psychiatry 2003; 37: 31–40
   PubMed Web of Science ®Google Scholar
• Andrews G, Hall W, Goldstein G, Lapsley H, Bartels R, Silove D. The economic costs of schizophrenia: implications for public policy. Archives of General Psychiatry 1985; 42: 537–543
   PubMed Web of Science ®Google Scholar
• Hall W, Andrews G, Goldstein G. The costs of schizophrenia. Australian and New Zealand Journal of Psychiatry 1985; 19: 3–5
   PubMed Web of Science ®Google Scholar
• Andrews G. The cost of schizophrenia revisited. Schizophrenia Bulletin 1991; 17: 389–394
   PubMed Web of Science ®Google Scholar
• Langley-Hawthorne C. Modeling the lifetime costs of treating schizophrenia in Australia. Clinical Therapeutics 1997; 19: 1470–1495
   PubMed Web of Science ®Google Scholar
• Singh B, Hawthorne G, Vos T. The role of economic evaluation in mental health care. Australian and New Zealand Journal of Psychiatry 2001; 35: 104–117
   PubMed Web of Science ®Google Scholar
• Davies A, Langley P C, Keks N A, Catts S V, Lambert T, Schweitzer I. Resperidone versus Haloperidol. II. Cost-effectiveness. Clinical Therapeutics 1998; 20: 196–213
   PubMed Web of Science ®Google Scholar
• Mihalopoulos C, McGorry P D, Carter R C. Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome?. Acta Psychiatrica Scandinavica 1999; 100: 47–55
   PubMed Web of Science ®Google Scholar
• Andrews G. Managing scarcity: a worked example using burden and efficacy. Australasian Psychiatry 1997; 5: 225–227
   Google Scholar
• Jablensky A, McGrath J, Herrman H, Castle D, Gureje O, Morgan V, Korten A. People living with psychotic illness: an Australian study 1997–98. National Survey of Mental Health and Wellbeing. Mental Health Branch Australian Commonwealth Department of Health and Aged Care, Canberra 1999, Report 4
   Google Scholar
• Jablensky A, McGrath J, Herrman H, et al. Psychotic disorders in urban areas: an overview of the methods and findings of the study on low prevalence disorders. Australian and New Zealand Journal of Psychiatry 2000; 34: 221–236
   PubMed Web of Science ®Google Scholar
• Carr V, Neil A, Halpin S, Holmes S. Costs of psychosis in urban Australia. A bulletin of the Low Prevalence Disorders Study. Canberra: Mental Health Branch Australian Commonwealth Department of Health and Aged Care. 2002, [Cited 17 October 2002.] Available from URL: http://www.health.gov.au/hsdd/mentalhe/resources/reports/costs.htm
   Google Scholar
• Knapp M, Almond S, Percudani M. Costs of schizophrenia: a review. Schizophrenia WPA series in evidence and experience in psychiatry, M Maj, N Sartorius. Wiley, Chichester 1999; 2: 407–454
   Google Scholar
• Goeree R, O'Brien B J, Goering P, et al. The economic burden of schizophrenia in Canada. Canadian Journal of Psychiatry 1999; 44: 464–472
   PubMed Web of Science ®Google Scholar
• Carr V J, Lewin T J, Barnard R E, et al. Comparisons between schizophrenia patients recruited from Australian general practices and public mental health services. Acta Psychiatrica Scandinavica 2002; 105: 346–355
   PubMed Web of Science ®Google Scholar
• Singh B S, McGorry P D. The Second National Mental Health Plan: an opportunity to take stock and move forward. Medical Journal of Australia 1998; 169: 435–437
   PubMed Web of Science ®Google Scholar
• Andrews G. Meeting the unmet need with disease management. Unmet need in psychiatry: problems, resources, responses, G Andrews, S Henderson. Cambridge University Press, Cambridge 2000; 11–36
   Google Scholar
• Calman K C. The ethics of allocation of scarce health care resources: a view from the centre. Journal of Medical Ethics 1994; 20: 71–74
   PubMed Web of Science ®Google Scholar
• Andrews G. Is schizophrenia worth the cost?. Schizophrenia WPA series in evidence and experience in psychiatry, M Maj, N Sartorius. Wiley, Chichester 1999; 2: 455–457
   Google Scholar
• Nord E, Pinto J L, Richardson J, Menzel P, Ubel P. Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Economics 1999; 8: 25–39
   PubMed Web of Science ®Google Scholar
• Ubel P A, Nord E, Gold M, Menzel P, Prades J LP, Richardson J. Improving value measurement in cost-effectiveness analysis. Medical Care 2000; 38: 892–901
   PubMed Web of Science ®Google Scholar
• Murray C JL, Lopez A D. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020, C JL Murray, A D Lopez. Harvard School of Public Health on behalf of the World Health Organization and the World Bank, Cambridge 1966
   Google Scholar
• Williams A. Calculating the global burden of disease: time for a strategic reappraisal?. Health Economics 1999; 8: 1–8
   PubMed Web of Science ®Google Scholar
• Mooney G, Wiseman V. Burden of disease and priority setting. Health Economics 2000; 9: 369–372
   PubMed Web of Science ®Google Scholar
• Murray C JL, Lopez A D. Progress and directions in refining the global burden of disease approach: a response to Williams. Health Economics 2000; 9: 69–82
   PubMed Web of Science ®Google Scholar
• Williams A. Comments on the response by Murray and Lopez. Health Economics 2000; 9: 83–86
   PubMed Web of Science ®Google Scholar
• Evans D B, Hurley S F. The application of economic evaluation techniques in the health sector: the state of the art. Journal of International Development 1995; 7: 503–524
   Google Scholar
• Anand S, Hanson K. Disability-adjusted life years: a critical review. Journal of Health Economics 1997; 16: 685–702
   PubMed Web of Science ®Google Scholar
• Goldman H H, Thelander S, Westrin C-G. Organizing mental health services: an evidence-based approach. Journal of Mental Health Policy and Economics 2000; 3: 69–75
   PubMedGoogle Scholar
• Andrews G, Sanderson K, Corry J, Lapsley H M. Using epidemiological data to model efficiency in reducing the burden of depression. Journal of Mental Health Policy and Economics 2000; 3: 175–186
   PubMedGoogle Scholar
• Rice D P. Cost of illness studies–fact or fiction. Lancet 1994; 344: 1519–1520
   PubMed Web of Science ®Google Scholar
• Mugford M, Cooper N J. The value of COI studies, Electronic responses to: Byford S, Torgerson DJ, Raftery J. Economic note: cost of illness studies. [Cited 17 May, 2000.] Available from URL: http://www.bmj.com/cgi/eletters/320/7245/ 1335#EL1
   Google Scholar
• Andrews G, Sanderson K, Slade T, Issakidis C. Why does the burden of disease persist? Relating the burden of anxiety and depression to effectiveness of treatment. Bulletin of the World Health Organization 2000; 78: 446–454
   PubMed Web of Science ®Google Scholar
• Marshall M, Lockwood A. Assertive community treatment for people with severe mental disorders (Cochrane Review). The Cochrane Library. Update Software, Oxford 2002, Issue 1
   Google Scholar
• Pharoah F M, Mari J J, Streiner D. Family intervention of schizophrenia (Cochrane Review). The Cochrane Library. Update Software, Oxford 2002, Issue 1
   Google Scholar
• Pekkala E, Merinder L. Psychoeducation for schizophrenia (Cochrane Review). The Cochrane Library. Update Software, Oxford 2002, Issue 1
   Google Scholar
• Crowther R, Marshall M, Bond G, Huxley P. Vocational rehabilitation for people with severe mental illness (Cochrane Review). The Cochrane Library. Update Software, Oxford 2002, Issue 1
   Google Scholar
• Cormac I, Jones C, Campbell C. Cognitive behaviour therapy for schizophrenia (Cochrane Review). The Cochrane Library. Update Software, Oxford 2002, Issue 1
   Google Scholar
• McGlashen T H. Early detection and intervention in schizophrenia research. Schizophrenia Bulletin 1996; 22: 327–345
   PubMed Web of Science ®Google Scholar
• McGorry P D. The nature of schizophrenia: signposts to prevention. Australian and New Zealand Journal of Psychiatry 2000; 34(Suppl.)14–21
   PubMed Web of Science ®Google Scholar
• Nathan P E, Gorman J M. A guide to treatments that work. Oxford University Press, New York 1998
   Google Scholar
• Mueser K T, Drake R E, Bond G R. Recent advances in psychiatric rehabilitation for patients with severe mental illness. Harvard Review of Psychiatry 1997; 5: 123–137
   PubMed Web of Science ®Google Scholar
• Mueser K T, Bond G R, Drake R E. Community-based treatment of schizophrenia and other severe mental disorders: treatment outcomes?. Medscape Psychiatry and Mental Health Journal 2001; 6, [Cited 15 October 2002.] Available from URL: http://www.medscape.com/viewarticle/430529
   Google Scholar
• Crowther R E, Marshall M, Bond G R, Huxley P. Helping people with severe mental illness to obtain work. British Medical Journal 2001; 322: 204–208
   PubMed Web of Science ®Google Scholar
• Healey A, Knapp M, Astin J, et al. Cost-effectiveness evaluation of compliance therapy for people with psychosis. British Journal of Psychiatry 1998; 172: 420–424
   PubMed Web of Science ®Google Scholar